Evidence map›Paper›PMID 20197555›Full record

ArticleBlood2010

Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.

Niccolò Bolli, Elspeth M Payne, Clemens Grabher, Jeong-Soo Lee, Adam B Johnston, Brunangelo Falini, John P Kanki, A Thomas Look

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Influence of Nucleophosmin (Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  3. Review
  4. Depletion ofFrontiers in hematology · 2023
    Article
  5. Article
  6. Zebrafish models of acute leukemias: Current models and future directions.Wiley interdisciplinary reviews. Developmental biology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Modeling hematopoietic disorders in zebrafish.Disease models & mechanisms · 2019
    Review
  14. Review
  15. Haematologica · 2019
    Article
  16. Article
  17. Disruption ofDisease models & mechanisms · 2019
    Article
  18. Genetic Models of Leukemia in Zebrafish.Frontiers in cell and developmental biology · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Niccolò BolliDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Elspeth M Payne
Clemens Grabher
Jeong-Soo Lee
Adam B Johnston
Brunangelo Falini
John P Kanki
A Thomas Look
Dana-Farber Cancer Institute · USHarvard University · USUniversity of Perugia · IT

Funding

Pathobiology of Cancer at the Host and Population LevelT32CA009382 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI YUAN, ZHI-MIN · 1985 to 2012
$2.9M
NCI NIH HHS 5T32-CA009382-26NCI NIH HHS T32 CA009382
6 · The paper itself

Abstract

Mutations in the human nucleophosmin (NPM1) gene are the most frequent genetic alteration in adult acute myeloid leukemias (AMLs) and result in aberrant cytoplasmic translocation of this nucleolar phosphoprotein (NPMc+). However, underlying mechanisms leading to leukemogenesis remain unknown. To address this issue, we took advantage of the zebrafish model organism, which expresses 2 genes orthologous to human NPM1, referred to as npm1a and npm1b. Both genes are ubiquitously expressed, and their knockdown produces a reduction in myeloid cell numbers that is specifically rescued by NPM1 expression. In zebrafish, wild-type human NPM1 is nucleolar while NPMc+ is cytoplasmic, as in human AML, and both interact with endogenous zebrafish Npm1a and Npm1b. Forced NPMc+ expression in zebrafish causes an increase in pu.1(+) primitive early myeloid cells. A more marked perturbation of myelopoiesis occurs in p53(m/m) embryos expressing NPMc+, where mpx(+) and csf1r(+) cell numbers are also expanded. Importantly, NPMc+ expression results in increased numbers of definitive hematopoietic cells, including erythromyeloid progenitors in the posterior blood island and c-myb/cd41(+) cells in the ventral wall of the aorta. These results are likely to be relevant to human NPMc+ AML, where the observed NPMc+ multilineage expression pattern implies transformation of a multipotent stem or progenitor cell.

Indexed as

AnimalsApoptosisBase SequenceBlotting, WesternCell SeparationCytoplasmEmbryo, NonmammalianFlow CytometryFluorescent Antibody TechniqueHematopoiesisHematopoietic Stem CellsHumansImmunoprecipitationLeukemia, Myeloid, AcuteMolecular Sequence DataMutationNPM1 protein, humanNuclear ProteinsNucleophosmin

Identifiers

PMID20197555
PMCPMC2858496
OpenAlexW1998849260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.